It all goes to show how a good idea can’t be kept down. Madam Curie started radiopharmaceuticals in the late 1800s and now it’s a multibillion-dollar industry. On Monday, April 3, BioWorld launches an eight-part series on the new era of radiopharmaceuticals, a key to cancer treatments that have fewer side effects and cause far less damage to tissue than before. The big idea is taking the hallmarks of two cancer therapies – radiology and chemotherapy – and merging them. That’s what makes this evolving technology a disrupter.